Abstract
About 5% of asthmatics do not behave like ‘classical’ asthmatics and may not respond adequately to conventional therapy. The terms used to describe such non-responders include severe, refractory, near fatal, difficult and difficult to control asthma. Within the umbrella term of severe or refectory asthma, there are distinct sub-phenotypes including brittle asthma. Brittle asthma is rare and may occur in 0.05% of all asthmatics. Currently the diagnosis of brittle asthma is made on clinical grounds based on the variability of peak flow and uncertainty and unpredictability of sudden onset of disabling and severe symptoms despite maximal medical therapy with high dose inhaled corticosteroids, inhaled and nebulised bronchodilators and either maintenance or repeated courses of systemic corticosteroids. The role of genetics, environmental exposure and infection is the focus of ongoing research in the development of severe asthma. Atopy, female sex and psychosocial factors are recognised to be associated with brittle asthma. Other factors, investigated as possible initiating or contributing factors in brittle asthma include nutrient deficiency, reduced antioxidants activity and immunodeficiency with low IgG subclass levels. This review will highlight the related phenotypes, risk factors, mortality and morbidity, pathogenesis and management of patients with brittle asthma.
Keywords: Brittle asthma, refractory asthma, related phenotypes, severe asthma, pathogenesis, risk factors, management
Current Respiratory Medicine Reviews
Title: Brittle Asthma
Volume: 3 Issue: 1
Author(s): Raana Haqqee and Syed Hasan Arshad
Affiliation:
Keywords: Brittle asthma, refractory asthma, related phenotypes, severe asthma, pathogenesis, risk factors, management
Abstract: About 5% of asthmatics do not behave like ‘classical’ asthmatics and may not respond adequately to conventional therapy. The terms used to describe such non-responders include severe, refractory, near fatal, difficult and difficult to control asthma. Within the umbrella term of severe or refectory asthma, there are distinct sub-phenotypes including brittle asthma. Brittle asthma is rare and may occur in 0.05% of all asthmatics. Currently the diagnosis of brittle asthma is made on clinical grounds based on the variability of peak flow and uncertainty and unpredictability of sudden onset of disabling and severe symptoms despite maximal medical therapy with high dose inhaled corticosteroids, inhaled and nebulised bronchodilators and either maintenance or repeated courses of systemic corticosteroids. The role of genetics, environmental exposure and infection is the focus of ongoing research in the development of severe asthma. Atopy, female sex and psychosocial factors are recognised to be associated with brittle asthma. Other factors, investigated as possible initiating or contributing factors in brittle asthma include nutrient deficiency, reduced antioxidants activity and immunodeficiency with low IgG subclass levels. This review will highlight the related phenotypes, risk factors, mortality and morbidity, pathogenesis and management of patients with brittle asthma.
Export Options
About this article
Cite this article as:
Haqqee Raana and Arshad Syed Hasan, Brittle Asthma, Current Respiratory Medicine Reviews 2007; 3 (1) . https://dx.doi.org/10.2174/157339807779941712
DOI https://dx.doi.org/10.2174/157339807779941712 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heat Shock Paradox and a New Role of Heat Shock Proteins and their Receptors as Anti-Inflammation Targets
Inflammation & Allergy - Drug Targets (Discontinued) Gold Salts Therapy in Respiratory Diseases
Current Respiratory Medicine Reviews Infrequent Infections in COPD
Current Respiratory Medicine Reviews Synthesis of Pyrimidine-Annulated Five-Membered Heterocycles: An Overview
Current Organic Chemistry Design and Development of Preservative Free Herbal Dosage Forms
The Natural Products Journal Policies to Prevent Tobacco Use and Exposure in Children, a Global Perspective
Current Pediatric Reviews A Sensitive Voltammetric Sensor for Detecting Betamethasone in Biological Fluids
Combinatorial Chemistry & High Throughput Screening Natural Therapies of the Inflammatory Bowel Disease: The Case of Rutin and its Aglycone, Quercetin
Mini-Reviews in Medicinal Chemistry GSTP1 Polymorphisms and their Association with Glutathione Transferase and Peroxidase Activities in Patients with Motor Neuron Disease
CNS & Neurological Disorders - Drug Targets Gene Therapy for Allergic Diseases
Current Gene Therapy The Life and Death of Protein Kinase C
Current Drug Targets The Role of Oxidative Stress in Smoking-Related Diseases
Mini-Reviews in Organic Chemistry P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future
Current Pharmaceutical Design A Review on Molecular Mechanisms and Patents of Marine-derived Anti-thrombotic Agents
Current Drug Targets Evaluating the Effect of Cinnarizine on Promastigotes and Amastigotes forms of Leishmania major
Infectious Disorders - Drug Targets Computational Studies of Budesonide vs. Vilanterol: Asthma Drugs Against SARS-CoV-2 M<sup>pro</sup>
Current Chinese Science New Pharmacological Approaches to the Cholinergic System: An Overview on Muscarinic Receptor Ligands and Cholinesterase Inhibitors
Recent Patents on CNS Drug Discovery (Discontinued) Phenanthroindolizidines and Phenanthroquinolizidines: Promising Alkaloids for Anti-Cancer Therapy
Current Bioactive Compounds Antinflammatory Effects of Allergen Immunotherapy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Angina in Women without Obstructive Coronary Artery Disease
Current Cardiology Reviews